Filing Details

Accession Number:
0001415889-22-000167
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-04 15:23:08
Reporting Period:
2022-01-03
Accepted Time:
2022-01-04 15:23:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818844 Virios Therapeutics Inc. VIRI Pharmaceutical Preparations (2834) 854314201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826115 William Pridgen C/O Virios Therapeutics, Inc.
44 Milton Avenue
Alpharetta GA 30009
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-03 2,215 $5.43 14,542 No 4 P Indirect 401 (k) Account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect 401 (k) Account
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 710,734 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.20 to $5.70, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
  2. The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.